NORWEGIAN AMERICAN HOSPITAL
1. Target Overview & Investment Thesis
NORWEGIAN AMERICAN HOSPITAL is a 173-bed under-performing / distressed in COOK, IL with $115.3M in net patient revenue and a -17.1% operating margin. The hospital serves a payer mix of 19.8% Medicare, 8.6% Medicaid, and 71.6% commercial.
Thesis: Undervalued. Our ML models identify $8.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -17.1% to -9.8% (+736bps).
| Net Revenue HCRIS | $115.3M |
| Current EBITDA COMPUTED | $-19.8M |
| Operating Margin COMPUTED | -17.1% |
| Occupancy HCRIS | 51.9% |
| Revenue / Bed COMPUTED | $666K |
| Net-to-Gross HCRIS | 33.0% |
| Distress Probability ML | 49.9% |
2. Market Context & Competitive Position
IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of -17.1% places it below the state median. Among 98 size-comparable peers (86-346 beds), the median margin is -7.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (86-346), prioritizing same-state peers. 98 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| NORWEGIAN AMERICAN HOSPITAL (Target) | IL | 173 | $115.3M | -17.1% |
| SWEDISHAMERICAN HOSPITAL | IL | 324 | $752.0M | -2.8% |
| ADVOCATE NORTHSIDE HEALTH SYST | IL | 233 | $713.2M | 18.5% |
| NORTHERN ILLINOIS MEDICAL CENT | IL | 259 | $640.9M | -12.5% |
| BLESSING HOSPITAL | IL | 309 | $522.4M | -13.2% |
| NORTHWESTERN LAKE FOREST HOSPI | IL | 124 | $494.3M | -13.8% |
| SILVER CROSS HOSPITAL | IL | 296 | $479.7M | -1.1% |
| ALEXIAN BROTHERS MEDICAL CENTE | IL | 282 | $474.5M | -4.7% |
| SARAH BUSH LINCOLN HEALTH CENT | IL | 100 | $448.6M | -18.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $74K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-19.8M |
| + RCM Uplift | +$8.5M |
| Pro Forma EBITDA | $-11.3M |
| Current Margin | -17.1% |
| Pro Forma Margin | -9.8% |
| WC Released (1x) | $4.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-30.4M | $-45.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-30.4M | $-59.8M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-27.4M | $-41.7M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-27.4M | $-53.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-33.4M | $-78.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-33.4M | $-96.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 98 hospitals with 86-346 beds
- Same-state prioritization (n=99)
- Comp margins: P25=-20.8% / P50=-7.6% / P75=3.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.